Histologisk forbedring blev set, uanset baseline demografiske og hepatitis B karakteristika, herunder tidligere interferon- alfa terapi.
Histological improvement was seen regardless of baseline demographic and hepatitis B characteristics, including prior interferon-alpha therapy.